anti-Vasoactive Intestinal Peptide Receptor 1 (VIPR1) Antikörper

VIPR1 encodes a receptor for vasoactive intestinal peptide, a small neuropeptide. Zusätzlich bieten wir Ihnen Vasoactive Intestinal Peptide Receptor 1 Kits (19) und Vasoactive Intestinal Peptide Receptor 1 Proteine (6) und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
VIPR1 7433 P32241
VIPR1 22354 P97751
VIPR1 24875 P30083
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-Vasoactive Intestinal Peptide Receptor 1 Antikörper auf antikoerper-online.de

Showing 10 out of 133 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Lieferzeit Preis Details
Human Kaninchen Unkonjugiert WB Western blot analysis of VIPR1 expression in A549 (A), H9C2 (B), Raw264.7 (C) whole cell lysates. 200 μL 13 bis 14 Tage
$487.50
Details
Maus Ziege Unkonjugiert ELISA, WB   100 μg 6 bis 7 Tage
$429.84
Details
Human Kaninchen Unkonjugiert IF, ELISA, WB Western blot analysis of extracts from HT-29/K562 cells, using VIPR1 Antibody. The lane on the right is treated with the synthesized peptide. Immunofluorescence analysis of MCF7 cells, using VIPR1 Antibody. The picture on the right is treated with the synthesized peptide. 100 μg 2 bis 3 Tage
$302.50
Details
Maus Ziege Unkonjugiert ELISA Western Blot (2μg/ml) staining of Mouse (A) and Rat (B) Small Intestine lysate (35μg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence. 0.1 mg 2 bis 3 Tage
$515.63
Details
Human Kaninchen Unkonjugiert IHC, IHC (p) Anti-VIP Receptor 1 antibody  ABIN1049454 IHC staining of human adipocytes. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Anti-VIPR1 / RDC1 antibody IHC of human adrenal. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. 50 μg 11 bis 14 Tage
$484.00
Details
Human Kaninchen Unkonjugiert IHC, IHC (p) Anti-VIP Receptor 1 antibody  ABIN1049455 IHC staining of human adipocytes. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Anti-VIP Receptor 1 antibody IHC of human adipocytes. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. 50 μg 11 bis 14 Tage
$484.00
Details
Human Kaninchen Unkonjugiert ELISA, WB 100 μL Verfügbar
$363.46
Details
Human Kaninchen Unkonjugiert ELISA, IHC, IHC (p) Human Adrenal Medulla (formalin-fixed, paraffin-embedded) stained with VIPR1 antibody ABIN213444 at 20 ug/ml followed by biotinylated goat anti-rabbit IgG secondary antibody ABIN481713, alkaline phosphatase-streptavidin and chromogen. Anti-VIP Receptor 1 antibody IHC of human adrenal medulla. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. 50 μg 11 bis 14 Tage
$484.00
Details
Human Kaninchen Unkonjugiert ELISA, ICC, IF, WB Western blot analysis of extracts from HT-29 cells using VIPR1 antibody.The lane on the left is treated with the antigen-specific peptide. ABIN6276234 staining HT29 by IF/ICC. The sample were fixed with PFA and permeabilized in 0.1% Triton X-100,then blocked in 10% serum for 45 minutes at 25¡ãC. The primary antibody was diluted at 1/200 and incubated with the sample for 1 hour at 37¡ãC. An  Alexa Fluor 594 conjugated goat anti-rabbit IgG (H+L) Ab, diluted at 1/600, was used as the secondary antibod 100 μL 11 bis 12 Tage
$390.77
Details
Human Kaninchen Unkonjugiert WB Anti- VIPR1 antibody, Western blotting All lanes: Anti VIPR1  at 0.5ug/ml WB: Human Placenta Tissue Lysate at 50ug Predicted bind size: 52KD Observed bind size: 52KD 100 μg 4 bis 6 Tage
$240.00
Details

Am meisten referenzierte anti-Vasoactive Intestinal Peptide Receptor 1 Antikörper

  1. Human Polyclonal VIPR1 Primary Antibody für IHC (p) - ABIN4365549 : Berger, Vistisen, Barrett, Hazlett: Effects of VIP on corneal reconstitution and homeostasis following Pseudomonas aeruginosa induced keratitis. in Investigative ophthalmology & visual science 2012 (PubMed)

  2. Human Polyclonal VIPR1 Primary Antibody für ICC, IF - ABIN4365551 : Bertolini, Pretzlaff, Sulk, Bähr, Gherardini, Uchida, Reibelt, Kinori, Rossi, Bíró, Paus: Vasoactive intestinal peptide, whose receptor-mediated signalling may be defective in alopecia areata, provides protection from hair follicle immune privilege collapse. in The British journal of dermatology 2016 (PubMed)

Weitere Antikörper gegen Vasoactive Intestinal Peptide Receptor 1 Interaktionspartner

Human Vasoactive Intestinal Peptide Receptor 1 (VIPR1) Interaktionspartner

  1. In vitro-polarized macrophages by GM-CSF (GM-MO), with a proinflammatory profile, expressed higher levels of VIP receptors, vasoactive intestinal polypeptide receptors 1 and 2 (VPAC1 and VPAC2, respectively), than macrophages polarized by M-CSF (M-MO) with anti-inflammatory activities. RA synovial macrophages, according to their GM-CSF-like polarization state, expressed both VPAC1 and VPAC2.

  2. VPAC1 rs9677 CC genotype could be correlated with a reduced response to statin therapy and seems to be involved in diabetes cardiomyopathy in female patients with type 2 diabetes.

  3. The results reveal that more severe inflammation, based on high levels of IL-6, is associated with lower expression of VPAC1 and, conversely, with increased expression of VPAC2.

  4. variations at the 3'UTR of the VPAC-1 gene act synergistically to affect the expression of the luciferase as well as of the GFP reporter genes expressed in HEK293T cells.

  5. These data suggest that VPAC1 overexpression is associated with poorer differentiation of colon cancer, which is likely caused by subsequent EGFR activation in cancer cells.

  6. VIP regulates CFTR membrane expression and function in Calu-3 cells by increasing its interaction with NHERF1 and P-ERM in a VPAC1- and PKCepsilon-dependent manner.

  7. VPAC1 receptor has a role in endotoxemia in peripheral blood mononuclear cells

  8. The overexpression of VPAC1 and VPAC2 receptors and COX-2 in cancer tissue gives them a potential role as targets for diagnosis of prostate cancer.

  9. hree residues play an important role in VPAC1 interaction with the first histidine residue of VIP. These data demonstrate that VIP and PG97-269 bind to distinct domains of VPAC1

  10. The genetic association reported here indicates that VIP/VPAC1 signaling can be a relevant pathway in the pathogenesis of type 2 diabetes in females

  11. silencing of VPAC1 receptor inhibits vasoactive intestinal peptide effects on both EGF receptor and HER2 transactivation and vascular endothelial growth factor secretion in human breast cancer cells

  12. mRNA expression of the VPAC1 receptor was detected in 51% of the tumor specimens, while the incidence of mRNA expression for VPAC2 was 46%.

  13. increased expression in patients with allergic rhinitis

  14. The VIPR1 polymorphism, previously linked to gastrointestinal dysmotility disorders, does not represent a common risk factor for gallstones in the general or in an elderly population.

  15. Moreover, we report the markedly nuclear localization of VPAC(1) receptors in estrogen-dependent (T47D) and independent (MDA-MB-468) human breast cancer cell lines

  16. role of in MicroRNA 525-5p down-modulating VPAC1 expressio

  17. Results indicate that VPAC1, but not VPAC2 or PAC1, up-regulation in macrophages is a common mechanism in response to acute and chronic pro-inflammatory stimuli.

  18. We describe significant upregulation of the SPP1 gene, downregulation of VIPR1, and losses of the VIPR1 gene.

  19. Vasoactive intestinal peptide receptor-1 (VPAC-1) is a novel gene target of the hemolymphopoietic transcription factor Ikaros.

  20. VPAC1 is a cellular neuroendocrine receptor expressed on T cells that actively facilitates productive HIV-1 infection.

Mouse (Murine) Vasoactive Intestinal Peptide Receptor 1 (VIPR1) Interaktionspartner

  1. This study demonstrated that VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.

  2. VPAC1R mRNA expression was significantly decreased 3 days after ischemia induced by bilateral common carotid artery occlusion

  3. Cyclophosphamide-induced cystitis decreased VPAC1 receptor transcript expression in the urothelium of WT (4 h, 48 h, & chronic) & NGF-OE mice.

  4. Data support the notion that both VPAC1 and VPAC2 receptors are dynamically regulated by Ikaros, a master transcriptional regulator for thymocyte differentiation, during early thymic development.

  5. results support that decline in VIP/VPAC local levels may influence survival/apoptosis intracellular set point in NOD acinar cells and their clearance, contributing to gland homeostasis loss in a model of Sjogren's syndrome

  6. Homozygous deletion of VPAC1 resulted in fetal, neonatal, and postweaning death owing to failure to thrive, intestinal obstruction, and hypoglycemia.

  7. VIP enhancement of the severity of dextran sodium sulfate-induced colitis is mediated solely by VPAC1 receptors in mice.

  8. Data describe PACAP, vasoactive intestinal polypeptide, and PAC1, VPAC1, VPAC2 transcripts or protein expression in urothelium and detrusor smooth muscle and lumbosacral dorsal root ganglia in NGF-overexpressing and wildtype mice.

  9. VPAC(1)-R activation aggravates atherosclerotic lesion formation in apolipoprotein E-deficient mice through enhanced inflammatory activity in the vessel wall.

  10. VIP and its receptors (VPAC1, VPAC2) were identified in type II taste cells of the taste bud, and VIP knockout mice exhibit enhanced taste preference to sweet tastants.

  11. In contrast, selective VPAC(1) receptor activation shifts NSPC fate toward granule cell neurogenesis without any trophism.

  12. VPAC1 suggested as mediator of the neuroprotective effects of VIP

  13. VIP modulation of neural crest differentiation is mediated via VPAC1 and high expression of VPAC1 induces differentiation in and decreases tumorigenicity of neuroblastoma cells.

  14. VIP attenuated the experimental acute pancreatitis enzymatically and morphologically by inhibiting proinflammatory cytokine production from monocytes mainly through the VPAC1-R.

  15. In neonatal mice, a defect occurs in the signal transduction mechanism of the VPAC-1 VIP receptor and cortical astrocytes from neonatal brains are dysfunctional.

  16. VIP inhibits beta-amyloid protein (Abeta)-induced neurodegeneration by indirectly inhibiting production of a wide panel of inflammatory and neurotoxic agents by activated microglia cells.

  17. Data show that VIP and its receptors, VPAC1R and VPAC2R, are expressed in hippocampus, cortex, amygdala and hypothalamus which are involved in learned behaviors.

Rabbit Vasoactive Intestinal Peptide Receptor 1 (VIPR1) Interaktionspartner

  1. Implanting vascular bundles into the tissue engineered bone can significantly improve the expression levels of NK1R and VIPR1.

Zebrafish Vasoactive Intestinal Peptide Receptor 1 (VIPR1) Interaktionspartner

  1. signal pathways, transcript distribution, and splice variants are investigated

Pig (Porcine) Vasoactive Intestinal Peptide Receptor 1 (VIPR1) Interaktionspartner

  1. The study confirmed the presence of VPAC1 receptor in the tissues of the porcine female reproductive tract what clearly shows the possibility of influence of vasoactive intestinal polypeptide on the porcine ovary, oviduct and uterus.

Vasoactive Intestinal Peptide Receptor 1 (VIPR1) Antigen-Profil

Protein Überblick

This gene encodes a receptor for vasoactive intestinal peptide, a small neuropeptide. Vasoactive intestinal peptide is involved in smooth muscle relaxation, exocrine and endocrine secretion, and water and ion flux in lung and intestinal epithelia. Its actions are effected through integral membrane receptors associated with a guanine nucleotide binding protein which activates adenylate cyclase. Several transcript variants encoding different isoforms have been found for this gene.

Genbezeichner und Symbole assoziert mit VIPR1

  • vasoactive intestinal peptide receptor 1 (VIPR1) Antikörper
  • vasoactive intestinal peptide receptor 1 (Vipr1) Antikörper
  • vasoactive intestinal peptide receptor 1b (vipr1b) Antikörper
  • vasoactive intestinal peptide receptor 1 (vipr1) Antikörper
  • vasoactive intestinal peptide receptor 1 S homeolog (vipr1.S) Antikörper
  • vasoactive intestinal polypeptide receptor (LOC100303683) Antikörper
  • AV071699 Antikörper
  • CVIPR Antikörper
  • hvr1 Antikörper
  • II Antikörper
  • LOC100226500 Antikörper
  • PACAP-R-2 Antikörper
  • PACAP-R2 Antikörper
  • RATVASREC Antikörper
  • rdc1 Antikörper
  • v1rg Antikörper
  • vapc1 Antikörper
  • VASREC Antikörper
  • VIP-R Antikörper
  • VIP-R-1 Antikörper
  • VIP-R1 Antikörper
  • vipr Antikörper
  • vipr1 Antikörper
  • virg Antikörper
  • vpac1 Antikörper
  • vpac1-r Antikörper
  • VPAC1R Antikörper
  • vpcap1 Antikörper
  • VPCAP1R Antikörper

Bezeichner auf Proteinebene für VIPR1

PACAP type II receptor , VIP and PACAP receptor 1 , VIP receptor, type I , pituitary adenylate cyclase activating polypeptide receptor, type II , vasoactive intestinal polypeptide receptor 1 , PACAP-R-2 , PACAP-R2 , VIP receptor subtype 1 , VIP-R-1 , pituitary adenylate cyclase-activating polypeptide type II receptor , Vasopressive intestinal peptide receptor , vasoactive intestinal peptide receptor 1 , vasoactive intestinal polypeptide receptor 1-like , vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide receptor 1 , VPAC1R , vpac1 receptor , vasoactive intestinal polypeptide receptor type 1 , VIP receptor , Vasoactive intestinal polypeptide receptor

GENE ID SPEZIES
7433 Homo sapiens
395329 Gallus gallus
22354 Mus musculus
24875 Rattus norvegicus
460291 Pan troglodytes
477035 Canis lupus familiaris
535858 Bos taurus
100009518 Oryctolagus cuniculus
100226500 Taeniopygia guttata
100396852 Callithrix jacchus
100466268 Ailuropoda melanoleuca
100500782 Ovis aries
100603830 Nomascus leucogenys
503868 Danio rerio
100136671 Oncorhynchus mykiss
100381144 Xenopus laevis
100155402 Sus scrofa
100303683 Meleagris gallopavo
Ausgewählte Anbieter für anti-Vasoactive Intestinal Peptide Receptor 1 (VIPR1) Antikörper
Haben Sie etwas anderes gesucht?